公司概述
WW International, Inc. operates as a provider of weight management products and services across the United States, Germany, Canada, and international markets, offering nutritional, activity, behavioral, and lifestyle tools for individual weight goals and for individuals using GLP-1 medications. The company functions within the Healthcare sector, specifically categorized under the Medical Care Facilities industry, which implies a focus on health-related services and facilities rather than traditional retail or manufacturing. In terms of scale, the company holds a market capitalization of $112.96M and reports an annual revenue of $710.64M, supported by a workforce of 3500 employees. These valuation and revenue figures indicate that while the company generates substantial top-line sales, its market cap suggests a specific positioning that does not yet command a premium valuation relative to its revenue base, reflecting a potentially undervalued status or significant headwinds in investor sentiment.
财务健康
The company's financial performance is characterized by a revenue of $710.64M and a net income of $1.06B, while EBITDA stands at $148.40M, revealing a distinct and anomalous gap between revenue and net income where net income significantly exceeds revenue. This discrepancy indicates a highly unusual cost structure or accounting treatment that results in a profit margin of 148.6%, suggesting that the net income figure does not follow traditional operational scaling relative to revenue. The company generated $23.84M in free cash flow, which represents a limited level of financial flexibility compared to its reported cash reserves of $160.28M and total debt of $468.62M. Margin analysis shows a robust gross margin of 71.7%, indicating high efficiency in production or pricing power, contrasted sharply by an operating margin of -5.4% which signals operational losses before interest and taxes. The balance sheet appears leveraged given a debt-to-equity ratio of 147.33, though the firm maintains a current ratio of 1.69 which indicates adequate short-term liquidity to cover immediate obligations. Regarding return metrics, the Return on Assets is 6.7%, while Return on Equity is N/A, suggesting that the company's asset utilization is positive but the equity-based return calculation is not currently applicable due to the financial structure.
估值评估
Valuation metrics for WW International, Inc. present a complex picture with a trailing P/E ratio of 1.49 and a forward P/E of -19.48, implying that the market expects earnings to deteriorate or be negative in the future period, causing the forward multiple to deviate significantly from the trailing multiple. The price-to-book ratio is 0.35, which indicates that the stock trades at a substantial discount to its book value, suggesting the market values the company's assets at less than 35% of their accounting book value. Alternative valuation metrics such as a price-to-sales ratio of 0.16 and an EV/EBITDA of 2.84 suggest that the market is pricing the stock based on low multiples relative to sales and enterprise value, reflecting caution regarding future profitability. The stock's 52-week price range spans from a low of $11.23 to a high of $46.95, and the current price sits well below the 52-week high, indicating recent volatility and a potential decline from peak market interest. The beta is listed as N/A, meaning that standard volatility metrics relative to the broader market index are not available for this specific ticker in the provided data.
Growth & Income
Growth dynamics for WW International, Inc. show a revenue growth of -11.7% year-over-year, while earnings growth is N/A, indicating that the company is currently experiencing a contraction in top-line sales rather than expansion. The absence of positive earnings growth alongside declining revenue suggests that the company's profitability challenges are aligned with or exacerbated by its shrinking revenue base. As a non-dividend payer, the company does not distribute a dividend yield, nor does it maintain a payout ratio, as both metrics are N/A or 0.0%, meaning the company retains all earnings rather than distributing them to shareholders. Consequently, the overall growth and income profile is defined by revenue contraction and a lack of dividend income, with the company relying on operational restructuring or market recovery to drive future value creation rather than shareholder distributions.